According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,50ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,89ย โฌ a decrease over its 2021 EPS that were of 3,30ย โฌ.